Zentalis Pharmaceuticals annual net profit margin
2024
Zentalis Pharmaceuticals's net profit margin was −245.96% for fiscal 2024.
View full Zentalis Pharmaceuticals company overview| Fiscal year | Period ended | Net profit margin | Change (percentage points) |
|---|---|---|---|
| 2024 | 2024-12-31 | −245.96% | — |
| Fiscal quarter | Period ended | Net profit margin | Change (percentage points) |
|---|---|---|---|
| Q4 2024 | 2024-12-31 | −176.71% | — |
| Q1 2024 | 2024-03-31 | 24.82% | — |
The latest reported quarter, Q4 2024, shows −176.71%.
Net profit margin measures the percentage of revenue remaining as net income after operating costs, interest, taxes, and other expenses. It shows how much bottom-line profit or loss a company generates from each dollar of revenue.
TickerStat calculates net profit margin as SEC-reported net income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Zentalis Pharmaceuticals source filings ↗